Related Experiment Videos
[Clinical tests with Nerisona cream (SH K 183 MB)]
Zeitschrift Fur Hautkrankheiten
|January 1, 1976
Summary
Nerisona Cream (SH K 183 MB) demonstrated high efficacy in treating weeping dermatoses, with 90% of patients showing good to very good results. This investigational cream also exhibited an excellent safety profile and desirable cosmetic properties.
Area of Science:
- Dermatology
- Pharmacology
- Clinical Research
Background:
- Weeping dermatoses represent a significant clinical challenge.
- The need for effective and safe topical treatments is ongoing.
- Investigational preparations require rigorous evaluation for efficacy and safety.
Purpose of the Study:
- To evaluate the efficacy of Nerisona Cream (SH K 183 MB) in patients with weeping dermatoses.
- To assess the safety and tolerability profile of Nerisona Cream.
- To determine the cosmetic properties of the investigational cream.
Main Methods:
- A clinical study involving 50 patients diagnosed with weeping dermatoses.
- Treatment administered using the investigational preparation Nerisona Cream (SH K 183 MB).
- Assessment of treatment outcomes, side effects, and cosmetic properties.
Main Results:
- Ninety percent (90%) of patients achieved very good or good therapeutic results.
- No instances of systemic or topical adverse effects were reported during the study.
- The cosmetic properties of Nerisona Cream were rated as very good by participants.
Conclusions:
- Nerisona Cream (SH K 183 MB) is a highly effective treatment for weeping dermatoses.
- The preparation is well-tolerated, with a favorable safety and cosmetic profile.
- Further clinical use of Nerisona Cream is warranted based on these findings.